Clinical Trial Update: Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window (ImpACT-24A) [NA]

View source ↗

Summary

The ImpACT-24A trial evaluating an implant to augment cerebral blood flow in acute ischemic stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: BrainsGate | Conditions: Acute Ischemic Stroke | NA | Status: TERMINATED